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Abstract
Background: Copy number variations (CNVs) are a significant source of genetic diversity and commonly found in
mammalian genomes. We have generated a genome-wide CNV map for Cynomolgus monkeys (Macaca fascicularis).
This crab-eating macaque is the closest animal model to humans that is used in biomedical research.
Results: We show that Cynomolgus monkey CNVs are in general much smaller in size than gene loci and are specific
to the population of origin. Genome-wide expression data from five vitally important organs demonstrates that CNVs
in close proximity to transcription start sites associate strongly with expression changes. Among these eQTL genes we
find an overrepresentation of genes involved in metabolism, receptor activity, and transcription.
Conclusion: These results provide evidence that CNVs shape tissue transcriptomes in monkey populations, potentially
offering an adaptive advantage. We suggest that this genetic diversity should be taken into account when using
Cynomolgus macaques as models.
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Background
Copy number variations (CNVs) are genetic differences
in the normal population displayed as microscopically
invisible deletions or amplifications of stretches of gen-
omic DNA ranging from 1 kilobase up to the megabase
scale [1]. CNVs are commonly found in the genomes of
humans [2], primates [3], rodents [4], or arthropods like
Drosophila melanogaster [5]. In humans, more than 6.2
million different CNVs mapping to ~500’000 genomic
regions have so far been identified [6]. They significantly
contribute to genetic variation, covering more nucleotide
content per genome than single nucleotide polymor-
phisms (e.g. approximately 0.8% of the length of the
human genome differs between two human individuals)
[7]. Furthermore CNVs exhibit a higher per-locus muta-
tion rate than single nucleotide polymorphisms (SNPs)
[8]. Since CNVs can reside in genomic regions harboring
genes they can alter gene dosage, disrupt coding se-
quences or modify the level and timing of gene expres-
sion for genes within the CNV [9, 10] and on its flanks
[4, 11–15]. These effects of CNVs are difficult to under-
stand and not necessarily predictable, but relevant for
many diseases [16–19] and pharmacological responses
like in the case of CYP2D6 CNVs [20].
Cynomolgus monkeys (Macaca fascicularis) are well-
established translational models for biomedical research
and drug testing. These non-human primates are one of
the closest animal model to humans with high genetic
similarity (~93% in nucleotide sequence identity), similar
anatomies, and very similar physiologies [21–23]. These
animals offer great promise as models for many aspects of
human health and disease. Cynomolgus monkeys are out-
bred species, caught in the wild in many different places of
peninsular Southeast Asia, the Philippines, and Mauritius,
and used to found and continuously refresh breeding pro-
grams [23, 24]. They exhibit substantial levels of genetic
variation which can affect the outcome and interpretation
of biomedical studies [25–28]. Understanding of the con-
tribution of this variation to phenotypes is lagging behind
in Cynomolgus monkeys compared to the knowledge
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about human genetic and genomic variation [23]. Genome-
wide catalogs of SNPs start to emerge for Cynomolgus
monkeys with more and more genome sequencing projects
published [21, 29–32]. However, information on structural
variants, such as CNVs, is not available for Cynomolgus
monkeys despite their prominent role in phenotypic vari-
ation. In this study, we comprehensively assess for the first
time genome-wide copy number variation among Cyno-
molgus monkeys from cohorts used in pharmaceutical
studies using a custom 4.2 million probes comparative
genomic hybridization (CGH) array. To investigate the po-
tential functional implications of the detected copy number
variation, we used a Cynomolgus monkey specific gene
expression microarray to associate CNV genotypes with ex-
pression changes of proximal genes using a cis expression
quantitative trait loci (cis-eQTL) mapping approach.
Results
CNVs in diverse Cynomolgus monkey populations
Following the recent sequencing of the Cynomolgus
monkey genome [21], we aimed at investigating CNVs
among Cynomolgus monkey cohorts used in pharma-
ceutical research. We performed comparative genomic
hybridization (CGH) using a Cynomolgus monkey spe-
cific high-resolution oligonucleotide tiling array with 4.2
million probes spanning the genome with a median spa-
cing of 598 bp. Germline DNAs from 21 animals with
different origin (Fig. 1a) were tested against a Cynomol-
gus monkey reference. The array data were normalized
using the NimbleGen DEVA software supplemented
with corrections for the GC-content [7] of the probes
and for wave artifacts along the chromosomes [33]. We
used three different CNV calling methods (R-GADA,
DNAcopy, CopyMap) to detect high confidence CNVs
[34–36]. The resulting CNV profiles were then merged
per individual and only CNVs called by at least two
methods were included in our analysis. We detected
between 1,364 and 5,583 (mean = 2,951, SD = 1,150)
autosomal CNVs per individual with on average slightly
more duplications (1,758) than deletions (1,192) (Fig. 1b,
Additional file 1: Table S1). To enable genotyping across
individuals, we merged the overlapping CNV calls between
animals into CNV regions (CNVRs). CNVs on the sex
chromosomes were not considered in this analysis due to
the lack of the Y-chromosome in the reference genome and
because of the bias resulting from comparative genomic
hybridization of female specimens relative to a male
reference, lower probe density, and greater mapping
uncertainty for these regions in the current assembly.
We inferred a total of 15,183 CNVRs, ranging from
2.3 to 693 kb in length with a median length of
8.4 kb (SD = 15.1 kb) (Fig. 1c). In total, these CNVRs
cover ~4% (~127 Mb) of the autosomal Cynomolgus mon-
key genome (Additional file 1: Table S2). Interestingly, 58%
of CNVRs were detected in only one population, however
76% (44% of total) of them were private to one individual.
19% of CNVRs were found in two, 11% in three and 12%
in all four populations (Fig. 1d).
To minimize genotyping errors we then calculated “quan-
titative genotypes”, defined as an individual’s median log2-
ratio of all CGH probes within a given CNVR, and used
these for all further analyses (Additional file 2: Table S3).
To shed light on the relationship between individual mon-
keys and their CNV profiles, we used unsupervised hier-
archical clustering and principal component analysis
(PCA). Hierarchical clustering of the CNV signals showed a
clear grouping of the samples by geographical origin
(Fig. 1e). PCA revealed also a clear separation of the indi-
viduals by their geographical origin, particularly in monkeys
originating from Mauritius (Additional file 1: Figure S1).
Interestingly, this finding was mainly driven by the second
principal component, whilst the first principal component
correlated with the duplication/deletion ratio of individual
monkeys (Fig. 1b). We assumed different population gen-
etic properties of duplications and deletions, similar to pre-
vious observations in great apes and humans [37, 38].
Therefore we performed PCA on deletions and duplica-
tions separately to assess which structural variant serves as
more reliable population genetic marker. In this analysis
deletion genotypes segregate most accurately Cynomolgus
monkeys according to the different island and mainland
populations (Fig. 1f and Additional file 1: Figure S1).
Gene expression and CNVs
Next we assessed the effect of CNVs on gene expression.
Using Cynomolgus monkey specific transcriptome-wide
gene expression arrays, we measured the expression levels
of 18,280 genes in five vitally important tissues (liver,
spleen, lung, heart, kidney) from the same 21 animals. We
associated the expression levels of each gene with CNVRs
residing within 1 Mb of the transcription start site (TSS)
for each tissue separately. Only CNVs detected in at least
two individuals (n = 7,266) were used for this cis expression
quantitative trait loci (cis-eQTL) analysis. Genome-wide
eQTL mapping was performed using fastQTL [39] and
correction for multiple testing was carried out in two steps.
First local permutations were applied to correct for mul-
tiple variants per gene [39] and then false discovery rate
(FDR) was calculated per tissue to account for mul-
tiple tested genes. Applying an FDR cutoff of 10%, we
mapped a total of 32 cis-eQTL genes across all five
tissues, ranging from two to twelve cis-eQTLs per tissue
(Fig. 2a, Additional file 1: Table S4). Closer inspection of
eQTL genes revealed in general lower average expression
levels than the tissue average (Fig. 2b), however this differ-
ence was only significant in heart (Wilcoxon rank sum
test, p = 0.005). Functional annotation using the DAVID
knowledgebase [40] showed that half of the eQTL genes
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encode for membrane proteins and that most eQTL genes
are involved in processes like metabolism, receptor activ-
ity, and transcription. Moreover ~2/3 of the eQTL genes
are associated with metabolic or cardiovascular diseases
(Additional file 1: Table S4).
Closer analysis of the CNV-eQTL associations revealed
increasing significance and frequency for CNVs in close
proximity to the transcription start site (TSS) (Fig. 2c). The
highest density of eQTL CNVs was found around 200 kb
upstream of the TSS (Fig. 2d), which usually marks DNaseI
hypersensitive regulatory DNA regions [41]. However,
eQTL CNVs were generally not found to be located more
often upstream of the TSS than downstream (Binomial
test, p = 0.56).
Previous research suggests that CNVs might affect gene
expression changes of multiple proximal genes [4]. We
therefore sought to discover additional, weaker associa-
tions within the detected eQTL regions, which we might
have missed in the genome-wide eQTL mapping. For each
eQTL region, all associations between genes within 1 Mb
of an eQTL gene’s TSS and the eQTL CNV were assessed
and corrected for multiple testing per region by Bonferroni
correction. A total of 12 additional associations were de-
tected in ten out of 31 non-overlapping eQTL regions.
Within these regions, on average 11.3% of genes were also
associated with the eQTL CNV and all associations
showed the same directionality as the eQTL.
Among the most significant associations we found a
group of olfactory receptor (OR) genes (OR4K17, OR5M9)
on Cynomolgus monkey chromosome 7 and 14 as well as
the ATP-binding cassette transporter 4 (ABCB4) on
chromosome 3, also known as multidrug resistance pro-
tein 3 (MDR3) (Additional file 1: Table S4). In close prox-
imity to the OR genes on chromosome 7 we detected a
duplication event associated with expression changes of
OR4K17 in kidney and in lung and OR4K13 in kidney
(Fig. 3, Additional file 1: Figure S2). Further investigation
of this eQTL region revealed additional associations with
(See figure on previous page.)
Fig. 1 CNV genotypes. a Geographic origin of four natural populations, from where the tested Cynomolgus monkeys were caught. b Number of
duplications and deletions detected per individual by combining three CNV calling approaches. c Size distribution of the inferred CNV regions
across all 21 individuals (n = 15,183). d Number of CNV regions detected among and across the four populations. e Hierarchical clustering of the
log2 − ratio genotypes of all CNV regions (n = 15,183) in 21 individuals. f Loadings of the first and second principal component based on a PCA
performed on the log2- ratio genotypes of all CNV regions with deletions (n = 8495) in 21 individuals
A B
C D
-1000 -500 0 500 1000
Distance to TSS (kb)
eQ
T
Ls
 (
de
ns
ity
)
2e
−
04
4e
−
04
6e
−
04
Tissue
Heart
Kidney
Liver
Lung
Spleen
eQ
T
L
gl
ob
al
eQ
T
L
gl
ob
al
eQ
T
L
gl
ob
al
eQ
T
L
gl
ob
al
eQ
T
L
gl
ob
al
6
8
10
12
14
lo
g 2
ex
pr
es
si
on
-1000 -500 0 500 1000
Distance to TSS (kb)
-lo
g 1
0 
no
m
in
al
 p
-v
al
ue
Tissue
Heart
Kidney
Liver
Lung
Spleen
5
6
7
8
9
Liver
Kidney
Heart
Spleen
Lung
Number of eQTLs
0 2 4 6 8 10 12
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OR4K13 in lung and OR4L1 in both kidney and lung. For
ABCB4 we detected a deletion ~480 kb upstream of its
TSS associated with increased transporter expression in
lung (Fig. 4, Additional file 1: Figure S3). Both examples
highlight the impact of intergenic CNVs on gene expres-
sion in a tissue specific manner.
Discussion
Taking advantage of the recently sequenced Cynomolgus
monkey genome, we developed species-specific microarrays
for CNV detection and transcriptome profiling to explore
CNV diversity, genome variation, and transcriptional con-
sequences in natural monkey populations. For this ap-
proach we developed a computational pipeline combining
careful data normalization and 3 different, non-redundant
CNV calling methods enabling us to assess copy number
variation in Cynomolgus monkeys at very high resolution
(>2 kb). According to our knowledge, this is the first study
to investigate natural copy number variation in this species.
We predominately find small CNVs among our indi-
viduals with a median length of about 8 kb. Technically,
this finding highlights the importance of a meticulous
CNV calling approach, since we operate close to the
resolution limit of the array with many CNVs encom-
passing only 5 probes. Biologically, this finding is in line
with current human genetic research, which suggests
that individuals from normal and healthy populations
carry mostly short CNVs (median length of 7.4 kb) [38].
Genome-wide mapping of CNVs to copy number vari-
able regions revealed that more than half of all CNVs
were population specific with a majority detected in only
one individual, suggesting that many of the population
specific CNVs are probably found at low frequency at
the respective loci. Genotyping of Cynomolgus monkeys
based on CNVs revealed a clustering by origin, clearly
separating the Mauritian and Philippine island popula-
tions from mainland populations, an effect probably me-
diated by genetic bottlenecks and geographical isolation.
For example Mauritian monkeys are descendants from a
small number of individuals brought to the island in the
16th century [31]. Separation between the Southeast
Asian and Vietnamese mainland populations is less pro-
nounced, in line with the fact that these two populations
share geographically adjacent biotops [23]. In this con-
text we also discovered that duplications are less inform-
ative than deletions as population genetic markers in
agreement with CNV profiling studies in great apes and
humans [37, 38]. These studies have shown that dele-
tions are less likely than duplications to be subjected to
recurrent mutation events. Hence deletions cannot
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change their copy number state so dynamically over a
short time period and are more likely to exhibit identity
by descent as a result of an ancestral mutation event.
Since the median gene locus size in Cynomolgus mon-
keys is 47 kb, the majority of CNVs are too small to delete
or alter the copy number of an entire gene making them
less likely to become an evolutionary constraint. Further-
more, short CNVs are more frequently generated de novo
than large CNVs (>500 kb) [42], which indicates that they
are not under strong purifying selection in contrast to
deleterious large CNVs [19]. Therefore the genomic re-
gions where most CNVs are found might be those where
copy number is less important or where CNVs affect regu-
latory regions (enhancers, insulators, silencers) that have
modulatory impact on gene expression. We find that a
relatively small number of CNV loci are associated with
gene expression changes, suggesting that most copy num-
ber variation have no link to gene expression regulation,
similar to single nucleotide variants. When looking at the
association strength of our eQTLs, it became evident that
the strongest associations are detected with variants close
to their targets’ TSS. This relationship between genetic
distance to TSS and stronger association effects appears
to be similar between CNVs and SNPs. However eQTL-
SNPs distribute more symmetrically in very close proxim-
ity to the TSS (within +/− 100 kb) [13, 43, 44], whilst our
eQTL-CNV distributions peak ~200 kb upstream of the
TSS. Therefore it is possible that eQTL-CNVs indicate
more tissue-specific regulatory DNA regions or enhancer
elements, whilst the majority of eQTL-SNPs mark general,
tissue-independent regulatory elements which tend to be
found in very close proximity to the TSS [45, 46]. Indeed,
almost all of the CNV-eQTLs identified in our study ex-
hibit tissue-specific effects. Furthermore, the eQTL-genes
show generally lower expression levels than the respective
tissue average. This observation might indicate, that highly
expressed genes are either depleted of regulatory variants
by purifying selection or that gene regulatory networks
can buffer the effects of regulatory variants. However,
lower expressed genes with insufficient network mediated
buffering might be more responsive to CNVs in regulatory
DNA regions. The resulting change in expression level
might offer an adaptive advantage in a tissue-specific man-
ner. In this respect, we highlight two particularly interest-
ing eQTL regions on Cynomolgus monkey chromosome 7
and 3. A duplication event on chromosome 7 changes the
expression levels of a group of OR genes in lung and kid-
ney from a very low level to a level close to the average
global gene expression. Although olfactory receptors are
typically not expected to be expressed in internal organs,
they belong to genes relevant to the immediate environ-
ment and have been found overrepresented amongst copy
number variable genes [47]. Recent studies highlighted a
role of such receptors in kidney where their chemosensory
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function plays a role in tracking of the chemical compos-
ition of blood and tubular fluids and the modulation of
renin secretion, blood pressure, and glomerular filtration
rate [48, 49]. On chromosome 3 we detected a deletion
event associated with increased expression of ABCB4 in
lung. This gene product is known to act as tumor suppres-
sor once overexpressed in lung cancer [50]. Since ABCB4
expression was shown to be regulated by epigenetic silen-
cing, a deletion 480 kb upstream of this gene might abol-
ish epigenetic control of transcription, possibly resulting
in constitutive overexpression. Carrier of such copy num-
ber variations modulating expression levels of a tumor
suppressor gene might benefit from protective advantages.
Conclusion
We describe for the first time substantial copy number
variation in natural Macaca fascicularis populations as
an additional genetic source of diversity and interindi-
vidual variation. We report several tissue specific associ-
ations between CNVs and expression levels of proximal
genes providing a molecular link for variable transcrip-
tional programs between individuals. As an example a
genomic region on chromosome 7, which harbors sev-
eral OR genes, shows an association between gene ex-
pression and a close-by duplication event in both kidney
and lung. Our data suggest that CNVs shape tissue tran-
scriptomes of vitally important organs, possibly offering
an adaptive advantage.
Methods
Ethics statement
All peripheral blood and tissue samples (heart, kidney,
liver, lung, spleen) used in this study were supplied by
AAALAC accredited contract research organizations.
Animal samples were taken from healthy, untreated ani-
mals of GLP drug-safety studies in accordance with
local, national and international regulations. All proce-
dures were approved by the Institutional Animal Care
and Use Committee (IACUC) and governmental agen-
cies responsible for animal welfare in compliance with
local laws and regulations.
Animal samples
Tissue samples for CGH and expression analysis were
taken from Cynomolus monkeys obtained from breeding
centers located in the Philippines (3 females and 3 males),
in Vietnam (2 males, 2 females), in China for animals from
Mainland Southeast Asia (3 females), or in Mauritius (4
females and 4 males) (Fig. 1a). Blood samples for CGH
analysis were taken from Cynomolgus monkeys with
Mauritian origin (25 males). Details (gender, weight, age,
origin) of all animals and their suppliers are on record and
were part of the data submitted to public databases.
NimbleGen gene expression analysis
Cynomolgus monkey tissues were homogenized in tubes
prefilled with 1.4 mm ceramic beads and QiaGen’s lysis
reagent RLT using a FastPrep-24 instrument (MP Bio-
medicals, Solon, OH, USA). Total RNA from lysates was
extracted using the RNeasy Mini kit combined with
DNase treatment on a solid support (Qiagen Inc., Valen-
cia, CA, USA). RNA quality assessment and quantifica-
tion was performed using microfluidic chip analysis on
an Agilent 2100 bioanalyzer (Agilent Technologies Inc.,
Santa Clara, CA, USA). On a Biomek FXp workstation
(Beckman Coulter Inc., Brea, CA, USA), 10 ng of total
RNA was used to prepare cDNA with the NuGen Ova-
tion Pico WTA System V2 (NuGEN Technologies, Inc.,
SanCarlos, CA, USA), followed Cy3 labeling of cDNA
with the Roche NimbleGen One Color DNA Labeling
Kit. NimbleGen 12x135K gene expression microarrays
(design: 120419_Cynomolgus_v5_TH_exp_HX12) were
hybridized with 4 μg of Cy3-labeled cDNA for 16 h at
42 °C and were washed and dried according to the man-
ufacturer’s instruction. Microarray data were collected
by confocal scanning using the Roche NimbleGen
MS200 Microarray scanner at 2 μm pixel resolution
(Roche NimbleGen, Inc., Madison, WI, USA). Nimble-
Gen probe intensities were subjected to Robust Multi-
Array Analysis (RMA) with background correction and
quantile normalization as implemented in the Nimble-
Scan Software, version 2.6 (Roche NimbleGen, Inc.,
Madison, WI). Averaged gene-level signal intensities
were summarized into gene calls and log2 transformed.
To summarize the major biology of genes, functional an-
notation was performed using the DAVID knowledge-
base version 6.8 (https://david.ncifcrf.gov/).
Comparative genomic hybridization arrays
Cynomolgus monkey spleen tissues were homogenized
in tubes prefilled with 1.4 mm ceramic beads and Qia-
Gen’s lysis reagent ALT using a FastPrep-24 instrument
(MP Biomedicals, Solon, OH, USA) and then incubated
with Proteinase K at 55 °C for 1 h followed by RNAse A
treatment at 25 °C for 2 min (Qiagen Inc., Valencia, CA).
Cynomolgus monkey blood specimens (200 μl) were in-
cubated at 70 °C for 10 min in QiaGen’s lysis reagent
ALT with Proteinase K and RNAse A. Genomic DNA
from lysates was extracted using the QIAamp Mini kit
(Qiagen Inc., Valencia, CA, USA). Assessment of unfrag-
mented, high molecular weight DNA and quantification
was performed using microfluidic chip analysis on an
Agilent 2100 bioanalyzer (Agilent Technologies Inc.,
Santa Clara, CA, USA). 0.5 μg of DNA from one animal
tissue at a time and 0.5 μg of reference DNA - pooled
DNA from blood specimens of 25 male Cynomolgus
monkeys — were used for labeling by an isothermal Kle-
now fill-in reaction with either Cy3 or Cy5 random
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nonamer primer using the Roche NimbleGen Dual color
labeling kit (Roche NimbleGen, Inc., Madison, WI). La-
beling Hybridization Controls were spiked-in as quality
controls for copy number variation detection (Roche
NimbleGen, Inc., Madison, WI).
NimbleGen 4.2 M CGH microarrays (design:
120405_Cynomolgus5_CGH_UX1) were hybridized with
34 μg of Cy3- and 34 μg of Cy5-labeled DNA for 72 h at
42 °C. After hybridization, microarrays were washed and
dried according to the manufacturer’s instruction, whereat
150 mM 1,3,5-Triaza-7 phospha-adamantane was included
in the last washing step to avoid interference of ozone with
the Cy5 dye during drying and scanning. Microarray data
were collected by confocal scanning using the Roche Nim-
bleGen MS200 Microarray Scanner at 2 μm pixel reso-
lution (Roche NimbleGen, Inc., Madison, WI, USA).
aCGH normalization
aCGH probe intensities were subjected to LOESS spatial
correction, background correction, and q-spline
normalization as implemented in the NimbleGen DEVA
software, version 1.2 (Roche NimbleGen, Inc., Madison,
WI). The data were then additionally normalized for probe
GC-content [7]. To estimate the effect of probe GC-
content on the measured log2-ratios, linear models were fit-
ted for each array according to following formula:
log2 Rið Þ ¼ αþ β1GCi þ β2GC2i þ εi
Where log2(Ri) is the measured log2 − ratio of an
aCGH probe i, a the intercept, GCi the probes GC con-
tent and εi a random error. The estimated effect of the
probe GC-content was then subtracted from the mea-
sured log2 − ratios (i.e. residualized). Furthermore the
data were normalized for wave artifacts along chromo-
somes as described by [33]. This was done by fitting a
local regression (LOESS) model for each chromosome
and array separately to estimate the effect of chromo-
somal position on the measured log2 − ratios:
log2 Rið Þ ¼ g posið Þ þ εi
Where g is the local regression function, posi denotes
the position of the probe i on the chromosome and εi a
random error. Because the fraction of the data used in
each local window (neighborhood) during model fitting
is a crucial parameter, the normalization was performed
across different fractions. The best was then selected
based on signal-to-noise ratio (SNR) improvements be-
fore and after normalization using a CNV test set. The
test set consisted of CNVs called based on the probe
GC-content normalized data using all three callers with
standard settings and the results were processed in the
same way as the final CNV calls (see: CNV calling). Only
CNVs detected in at least 2 individuals were retained for
more confident CNV calls. For each individual, the
signal-to-noise ratio of each aCGH probe in each CNV
of the test set was calculated in the following way:
SNRi ¼
log2 Rið Þ




σCi
SNRi denotes the signal-to-noise ratio of a given probe
i, and σCi the standard deviation of all probes on the
same chromosome as probe i. The average SNR of all
CNV probes per CGH array was used as metric to evalu-
ate the normalization performance. Using this approach,
a fraction of 4000 probes per model fitting step resulted
in the largest median SNR improvement (1.1%) and was
therefore chosen (Additional file 1: Figure S4, Table S5).
CNV calling
CNV calling was performed with 3 inherently different
approaches to mitigate method specific errors: R-GADA
[34] was used with the following parameters: alpha = 0.2,
T = 4.5, minseglen = 5. DNAcopy [35] was used with
minseglen = 5, undosd = 3, undoprune = 0.05 and data
smoothing was applied prior to CNV calling. CopyMap
[36] was used with r = 20, T = 4, m = 5, a = 2.1, P = 0.001.
Furthermore, for R-GADA and DNAcopy z-scores were
calculated for all CNV calls based on the mean log2 − ratio
of the CNV, and only CNVs with z-scores >1.5 or <−1.5
retained. For CNVs called by CopyMap a carrier probabil-
ity of at least 0.8 was required.
The three obtained CNV calling profiles per individual
were then merged and only CNVs called by at least two
methods were kept, and loci with conflicting copy num-
ber states were removed. These resulting profiles were
then further merged between individuals to obtain CNV
regions that could be genotyped across individuals. In
cases where an individual carried more than one CNV
in a CNV region, the locus was marked as a complex
locus and removed from subsequent steps. Additionally
CNV loci located on the X chromosome or within array
probe gaps larger than 500 kb + − 250 kb (e.g. centro-
meres) were removed. To avoid potential calling mis-
takes the median log2 − ratio of each CNV was used as
genotype rather than the discrete copy number state
provided by the CNV calling methods. PCA was per-
formed with the R-function princomp to visualize and
evaluate the inferred CNV genotypes together with hier-
archical clustering of the Pearson correlation between
log2 − ratios of samples.
eQTL analysis
To assess the potential functional impact of copy num-
ber variants, we associated the inferred CNV genotypes
with the expression level of proximal genes in each of
the five tissues by using a cis expression quantitative trait
Gschwind et al. BMC Genomics  (2017) 18:144 Page 8 of 10
loci (cis-eQTL) approach. No complex CNV loci were
used for that purpose and in order to avoid outlier driven
results only CNVs called in at least two individuals were
retained. The expression level of each gene was tested for
associations with all CNVs within 1 Mb of its transcription
start site (TSS) using following linear model:
Eit ¼ αþ β1Ci þ β2Git þ εit
Where Eit is the measured expression level of a gene E in
tissue t for the ith individual, Ci is the genotype of a prox-
imal CNV C for the ith individual and εit a random error.
To account for systematic confounding variation between
samples, the loadings of the first principal component for
individual i for the expression levels of all genes of the
same tissue (Git) was added as covariate. This was done to
account for global changes of the transcriptome resulting
from batch effects, population stratification or metabolic
state of an individual, which could lead to spurious associa-
tions. Multiple combinations of principal component co-
variates were tested and inspection of the results (data not
shown) revealed the most credible eQTLs when using the
loadings for the first principal component for gene expres-
sion levels as covariate. An adapted version of the fastQTL
software [39] was used to test all possible associations
using this model. Correction for multiple testing was car-
ried out in two steps, where first local permutations were
applied to correct for multiple variants per gene [39] and
then the false discovery rate (FDR) (q-value R-package,
Storey J., 2015) was calculated per tissue to account for
multiple tested genes. Only eQTLs below an FDR of 10%
were considered as significant.
To further investigate the impact of CNVs on the gene
expression landscape, genes within the regions of detected
eQTLs were investigated for further associations with the
eQTL CNV. The expression levels of all genes within 1 Mb
from the TSS of an eQTL gene were tested for an associ-
ation with the eQTL CNV with the same linear model as
used for eQTL mapping. Bonferroni correction was calcu-
lated for all tested associations per region and association
with a corrected p-value <0.05 were considered significant.
Additional files
Additional file 1: Figures S1 – S4 and Tables S1, S2, S4, S5.
Supplemental figures and tables on CNV calling and eQTL mapping.
(DOCX 1151 kb)
Additional file 2: Table S3. Quantitative genotypes for all 15,183
inferred CNV regions (CNVRs). chr represents the chromosome on which
the CNVR is located, while start and end indicate the coordinates of the
first respectively last CGH probe contained in the CNVR. length_kb is the
estimated CNVR length in kilobases. CNV_detection_status indicates
whether a CNVR contains only deletions (del), duplications (dup) or both
(cnv) and eqtl_mapping indicates whether a given CNVR was detected in
at least two individuals and was therefore used for cis-eQTL mapping (1)
or not (0). The columns thereafter are the quantitative genotypes defined
as an individual’s median log2-ratio of all CGH probes within a given
CNVR. (XLSX 5415 kb)
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